You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-PLK1 antibodySee all PLK1 primary antibodies ...
  • Description
    Rabbit polyclonal to PLK1
  • Tested applicationsELISA, WB more details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse
  • Immunogen

    Synthetic peptide derived from Human PLK1 around the phosphorylation site of threonine 210 (K-K-TP-L-C).

  • Positive controlExtracts from LOVO cells treated with PMA (125ng/ml, 30mins).

Properties

Applications

Our Abpromise guarantee covers the use of ab61118 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
ELISA ELISA: 1/20000.
WB WB: 1/500 - 1/1000. Detects a band of approximately 68 kDa (predicted molecular weight: 68 kDa).

Target

  • FunctionSerine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of APC/C inhibitors, and the regulation of mitotic exit and cytokinesis. Required for recovery after DNA damage checkpoint and entry into mitosis. Required for kinetochore localization of BUB1B. Phosphorylates SGOL1. Required for spindle pole localization of isoform 3 of SGOL1 and plays a role in regulating its centriole cohesion function. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Regulates TP53 stability through phosphorylation of TOPORS.
  • Tissue specificityPlacenta and colon.
  • Sequence similaritiesBelongs to the protein kinase superfamily. Ser/Thr protein kinase family. CDC5/Polo subfamily.
    Contains 2 POLO box domains.
    Contains 1 protein kinase domain.
  • Developmental stageAccumulates to a maximum during the G2 and M phases, declines to a nearly undetectable level following mitosis and throughout G1 phase, and then begins to accumulate again during S phase.
  • Post-translational
    modifications    Catalytic activity is enhanced by phosphorylation of Thr-210. Phosphorylation at Thr-210 is first detected on centrosomes in the G2 phase of the cell cycle, peaks in prometaphase and gradually disappears from centrosomes during anaphase.
    Autophosphorylation and phosphorylation of Ser-137 may not be significant for the activation of PLK1 during mitosis, but may enhance catalytic activity during recovery after DNA damage checkpoint.
    Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) in anaphase and following DNA damage, leading to its degradation by the proteasome. Ubiquitination is mediated via its interaction with FZR1/CDH1. Ubiquitination and subsequent degradation prevents entry into mitosis and is essential to maintain an efficient G2 DNA damage checkpoint.
  • Cellular localizationNucleus. Chromosome > centromere > kinetochore. Cytoplasm > cytoskeleton > centrosome. During early stages of mitosis, the phosphorylated form is detected on centrosomes and kinetochores. Localizes to the outer kinetochore. Presence of SGOL1 and interaction with the phosphorylated form of BUB1 is required for the kinetochore localization.

    • Target information above from: UniProt accession P53350 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
    • Alternative names
        Cell cycle regulated protein kinase antibodyPLK 1 antibodyPLK antibody
        PLK-1 antibodyplk1 antibodyPLK1_HUMAN antibodypolio like kinase antibodyPolo like kinase 1 antibodyPolo-like kinase 1 antibodySerine/threonine protein kinase antibodySerine/threonine protein kinase 13 antibodySerine/threonine protein kinase PLK1 antibodySerine/threonine-protein kinase 13 antibodySerine/threonine-protein kinase PLK1 antibodySTPK 13 antibodySTPK13 antibody
      see all

    Anti-PLK1 antibody images

    • Western blot - PLK1 antibody (ab61118)
      Western blot - PLK1 antibody (ab61118)
      All lanes : Anti-PLK1 antibody (ab61118) at 1/500 dilution

      Lane 1 : Extracts from LOVO cells treated with PMA (125ng/ml, 30mins)
      Lane 2 : Extracts from LOVO cells treated with PMA (125ng/ml, 30mins) with immunising PLK1 peptide


      Predicted band size : 68 kDa
      Observed band size : 68 kDa

    References for Anti-PLK1 antibody (ab61118)

    ab61118 has not yet been referenced specifically in any publications.

    Publishing research using ab61118 ? Please let us know so that we can cite the reference in this datasheet

    Product Wall

    Submit an Abreview for ab61118 Submit a Question for ab61118

    There are currently no Abreviews or Questions for ab61118.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"